A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/10/2002	WO2001093845A3 Carboxyalkylether-acat inhibitor combinations
10/10/2002	WO2001078780A1 Preventives/remedies for alzheimer's disease
10/10/2002	WO2001072728A9 Novel piperazine derivatives
10/10/2002	WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002	WO2001052867A9 Use of pentosan polysulfate to treat certain conditions of the prostate
10/10/2002	WO2001049678A9 Substituted phenyl-piperazine derivatives, their preparation and use
10/10/2002	US20020147997 Animal model for use in the diagnosis, prevention and treatment of cancer
10/10/2002	US20020147359 Neurokinin antagonist; antiinflammatory agents, antiallergens
10/10/2002	US20020147355 Animal extracts; uterine contractions; isolation by distillation, flash chromatography
10/10/2002	US20020147346 New crystal modification of torasemide
10/10/2002	US20020147345 FSH mimetics for the treatment of infertility
10/10/2002	US20020147344 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
10/10/2002	US20020147343 Cell antiproliferative agents; anticancer agents
10/10/2002	US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002	US20020147339 5-cyano-2-aminopyrimidine derivatives
10/10/2002	US20020147336 Glucocorticoid receptor modulators
10/10/2002	US20020147332 Novel nucleoside and oligonucleotide analogues
10/10/2002	US20020147318 Generation of water soluble carboxylmethyl chitosan; obtain crustaceans crusts, expose to basic solution, heat, recover chitosan, dissolve in isopropyl alcohol, dry, recover carboxyl methyl chitosan
10/10/2002	US20020147239 Esmolol formulation
10/10/2002	US20020147238 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen
10/10/2002	US20020147237 Preservation of bodily protein
10/10/2002	US20020147236 Controlling concentration; side effect reduction
10/10/2002	US20020147234 Nitrate esters and methods of making same
10/10/2002	US20020147233 Epoxyvibsanin B
10/10/2002	US20020147232 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
10/10/2002	US20020147231 Allosteric adenosine receptor modulators
10/10/2002	US20020147229 Pharmaceuticals
10/10/2002	US20020147228 Adjust concentration of albumin in blood
10/10/2002	US20020147226 Synergistic mixtures
10/10/2002	US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002	US20020147223 Agent for enhancing accumulation of drugs in tumor tissues
10/10/2002	US20020147220 Norcisapride; sleep disorders, eating disorders, irratible bowel disorders
10/10/2002	US20020147218 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
10/10/2002	US20020147217 The treatment of sexual dysfunction with enantiomers
10/10/2002	US20020147216 Mucin synthesis inhibitors
10/10/2002	US20020147215 Administering cilostazol or flosequinan
10/10/2002	US20020147214 Enzyme inhibitors; anticancer agents
10/10/2002	US20020147213 Side effect reduction; synergistic mixture
10/10/2002	US20020147211 Synergistic mixture of angiotensin inhibitors, boric acid, ethylenediaminetetraacetic acid and active drug
10/10/2002	US20020147210 Methods for delaying recurrence of herpes virus symptoms
10/10/2002	US20020147209 Cycloalkano-indole and -azaindole derivatives
10/10/2002	US20020147208 Anticancer agents; drug delivery to stomach
10/10/2002	US20020147206 Synergistic mixture of neurotransmitter and antidepressant
10/10/2002	US20020147205 Heterocyclic compounds
10/10/2002	US20020147203 Tyrosine kinase inhibitors
10/10/2002	US20020147202 Aqueous suspension; thermal sterilization
10/10/2002	US20020147201 Glycyrrhizin complex
10/10/2002	US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002	US20020147199 Process for the treatment of erectile dysfunction and product therefor
10/10/2002	US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002	US20020147197 Methods and compositions for enhancing pharmaceutical treatments
10/10/2002	US20020147196 Synergistic mixture of dopamine antagonist and sodium channel modulators
10/10/2002	US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002	US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002	US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002	US20020147189 Immunology response; autoimmune disease
10/10/2002	US20020147188 Protease inhibitors
10/10/2002	US20020147186 Side effect reduction
10/10/2002	US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/10/2002	US20020147184 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/10/2002	US20020147183 Angiogenesis inhibitors; antitumor agents, rheumatic diseases
10/10/2002	US20020147182 13-substituted methacycline compounds
10/10/2002	US20020147181 Viricides
10/10/2002	US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same
10/10/2002	US20020147178 6- (spirocyclopropyl) penicillanic acid 4, 4-dioxides
10/10/2002	US20020147177 Complexing with cyclodextrins; water solubility
10/10/2002	US20020147176 Thermoplastic and water-soluble cellulose ether esters
10/10/2002	US20020147174 Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy
10/10/2002	US20020147171 Viability of organs transplants
10/10/2002	US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
10/10/2002	US20020147161 Novel antisense inhibition of rad51
10/10/2002	US20020147160 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/10/2002	US20020147159 Sustained release; antidiabetic agents
10/10/2002	US20020147158 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
10/10/2002	US20020147157 Combination therapy comprising anti-diabetic and anticonvulsant agents
10/10/2002	US20020147156 Cellular uptake of bioactive agents
10/10/2002	US20020147155 Prevention and treatment of endometriosis with aryl hydrocarbon receptor binding ligands
10/10/2002	US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002	US20020147142 Methods and reducing or maintaining reduced levels of blood lipids using OB protein compositions
10/10/2002	US20020147139 Viricides
10/10/2002	US20020147138 Anticancer agents
10/10/2002	US20020147130 Treatment of hiv
10/10/2002	US20020146830 Methods and compositions for delivery of pharmaceutical agents
10/10/2002	US20020146826 Cationic polysaccharide compositions
10/10/2002	US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002	US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002	US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002	US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002	US20020146502 Sorbic acid as growth-stabilizing addition to feedstuffs for agricultural livestock rearing
10/10/2002	US20020146472 extract of black tea comprising theaflavin-3-gallate and theaflavin-3'-gallate; for inhibiting tumor cell growth in an animal; for therapy and prophylaxis of cancer, inflammation, and arthritis
10/10/2002	US20020146471 For maintenance of a state of wellness in which sexual health is improved
10/10/2002	US20020146469 Administering a sensory regimen which reduces or down-regulates the activity of the hypothalamus-pituitary-adrenal (HPA) axis
10/10/2002	US20020146468 Therapy and prophylaxis of diabetes by administering to a human or animal an effective dosage of an extract of plant of the genus Trichocaulon or of the genus Hoodia
10/10/2002	US20020146464 Mixing a chloride hydrargyrum material and a gypsum material and pork into particles, and frying particles into pills
10/10/2002	US20020146463 Useful as food additives or in medicaments
10/10/2002	US20020146461 Combining phase comprising wherein active agent, polymer, solvent and second phase; flowing emulsion through static mixers; combining outflow with extraction liquid for extracting solvent from emulsion to form microparticles
10/10/2002	US20020146460 Injecting into a patientaqueous suspension of solid particles suitable for intravenous delivery, the solid particles comprising a camptothecin, and a 0.3 nm to 3.0 mu m thick layer of a membrane-forming amphipathic lipid
10/10/2002	US20020146457 Preparing phase comprising a polymer, a psychotherapeutic agent, and solvent; preparing an aqueous phase and combining with first pahse to form emulsion; separation; reducing solvent in discontinuous phase
10/10/2002	US20020146456 Preparation of microparticles having improved flowability
10/10/2002	US20020146454 Active compound is prepared in aqueous solution/ suspension; sprayed onto neutral excipients, without isolating active compound as solid substance, and dried in parallel with this, or, mixing with binder granulating with excipients and drying

1 ... 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 5704 ... 7860